Deprescribing of non-antiretroviral therapy in HIV-infected patients José-Ramón BlancoRamón Morilloon behalf of Gesida and SEFH Review 21 December 2019 Pages: 305 - 318
Association between anticholinergic drug burden and mortality in older people: a systematic review Sheraz AliGregory M. PetersonMohammed S. Salahudeen Review 12 December 2019 Pages: 319 - 335
Comparison of drug-related problem risk assessment tools for older adults: a systematic review Emmi PuumalainenMarja AiraksinenMaarit Dimitrow Review Open access 10 December 2019 Pages: 337 - 348
Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia Shampa DasDiansong ZhouJianguo Li Review Open access 14 December 2019 Pages: 349 - 361
Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review Judith SysSimon Van CleynenbreugelJos Tournoy Review 14 December 2019 Pages: 363 - 381
Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers Xiao-yan ShengYan LiangYi-min Cui Clinical Trial 23 December 2019 Pages: 383 - 391
The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study. Jason W BolandVictoria AllgarMiriam Johnson Clinical Trial Open access 21 December 2019 Pages: 393 - 402
Evaluation of a modified vancomycin nomogram for obese adults Nathan BatchelderCarrie Faith LutheranJeremy Frens Clinical Trial 13 December 2019 Pages: 403 - 408
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis Fabio Alessandro FacchiniDavide Di FuscoIvan Monteleone Pharmacodynamics 25 January 2020 Pages: 409 - 418
Impact of genetic variants of selected cytochrome P450 isoenzymes on pharmacokinetics and pharmacodynamics of clopidogrel in patients co-treated with atorvastatin or rosuvastatin Marta Karaźniewicz-ŁadaDagmara KrzyżańskaPaweł Burchardt Pharmacogenetics 02 January 2020 Pages: 419 - 430
Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects Marie-Laure BoofAtef HalabiJasper Dingemanse Pharmacokinetics and Disposition 13 December 2019 Pages: 431 - 437
Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED) Katja S. JustHarald DormannJulia C. Stingl Pharmacoepidemiology and Prescription 12 December 2019 Pages: 439 - 448
Use of proton pump inhibitors in adults in France: a nationwide drug utilization study Marion LassalleThien Le TriRosemary Dray-Spira Pharmacoepidemiology and Prescription Open access 14 December 2019 Pages: 449 - 457
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people C FranchiPM MannucciI Ardoino Pharmacoepidemiology and Prescription 18 December 2019 Pages: 459 - 465
Fatal sulfasalazine-induced DRESS complicated by HHV-6 reactivation and hemophagocytic lymphohistiocytosis Helmi AmmarAbdelbaki AzouziChaker Ben Salem Letter to the Editor 18 December 2019 Pages: 467 - 468
Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients Nuggehally R. Srinivas Letter to the Editor 03 January 2020 Pages: 469 - 471
Response by Pei et al. to letters regarding article, “Pharmacokinetic study of imrecoxib in patients with renal insufficiency” Qi PeiJin-lian XieGuo-Ping Yang Letter to the Editor 02 January 2020 Pages: 473 - 474